TerrAscend Corp. (TSND.TO)

CAD 0.57

(7.55%)

Net Debt Summary of TerrAscend Corp.

  • TerrAscend Corp.'s latest annual net debt in 2023 was 303.74 Million USD , up 1.87% from previous year.
  • TerrAscend Corp.'s latest quarterly net debt in 2024 Q2 was 215.83 Million USD , down -28.23% from previous quarter.
  • TerrAscend Corp. reported annual net debt of 298.17 Million USD in 2022, up 79.11% from previous year.
  • TerrAscend Corp. reported annual net debt of 166.47 Million USD in 2021, down -14.94% from previous year.
  • TerrAscend Corp. reported quarterly net debt of 215.83 Million USD for 2024 Q2, down -28.23% from previous quarter.
  • TerrAscend Corp. reported quarterly net debt of 303.74 Million USD for 2023 FY, up 1.87% from previous quarter.

Annual Net Debt Chart of TerrAscend Corp. (2023 - 2016)

Historical Annual Net Debt of TerrAscend Corp. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 303.74 Million USD 1.87%
2022 298.17 Million USD 79.11%
2021 166.47 Million USD -14.94%
2020 195.7 Million CAD 112.57%
2019 92.06 Million CAD 1105.78%
2018 -9.15 Million CAD 82.33%
2017 -51.81 Million CAD -1454.79%
2016 -3.33 Million CAD 0.0%

Peer Net Debt Comparison of TerrAscend Corp.

Name Net Debt Net Debt Difference
Aurora Cannabis Inc. -8.64 Million CAD 3612.312%
Avicanna Inc. 1.32 Million CAD -22803.409%
Avant Brands Inc. 17.93 Million CAD -1594.059%
Cardiol Therapeutics Inc. -34.77 Million CAD 973.501%
Crescita Therapeutics Inc. -8.13 Million CAD 3835.639%
Knight Therapeutics Inc. 10.33 Million CAD -2840.414%
MediPharm Labs Corp. -15.68 Million CAD 2036.407%
OrganiGram Holdings Inc. -33.7 Million CAD 1001.079%
Canopy Growth Corporation 512.87 Million CAD 40.776%
Willow Biosciences Inc. -989 Thousand CAD 30812.314%
Auxly Cannabis Group Inc. 142.88 Million CAD -112.587%